149 related articles for article (PubMed ID: 12477584)
41. A two-center study evaluating the hemodynamic and pharmacodynamic effects of cisatracurium and vecuronium in patients undergoing coronary artery bypass surgery.
Searle NR; Thomson I; Dupont C; Cannon JE; Roy M; Rosenbloom M; Gagnon L; Carrier M
J Cardiothorac Vasc Anesth; 1999 Feb; 13(1):20-5. PubMed ID: 10069278
[TBL] [Abstract][Full Text] [Related]
42. The Effect of Anesthetic Choice (Sevoflurane Versus Desflurane) and Neuromuscular Management on Speed of Airway Reflex Recovery.
McKay RE; Hall KT; Hills N
Anesth Analg; 2016 Feb; 122(2):393-401. PubMed ID: 26569427
[TBL] [Abstract][Full Text] [Related]
43. The effect of d-tubocurarine priming on an ED95 dose of vecuronium bromide.
Miguel RV; Barlow IK; Dombrowski DL
J Clin Anesth; 1994; 6(2):106-9. PubMed ID: 7911306
[TBL] [Abstract][Full Text] [Related]
44. Potency and time course of action of rocuronium during desflurane and isoflurane anaesthesia.
Kumar N; Mirakhur RK; Symington MJ; McCarthy GJ
Br J Anaesth; 1996 Oct; 77(4):488-91. PubMed ID: 8942333
[TBL] [Abstract][Full Text] [Related]
45. The effects of nimodipine on vecuronium-induced neuromuscular blockade.
Aysel I; Hepaguşlar H; Balcioglu T; Uyar M
Eur J Anaesthesiol; 2000 Jun; 17(6):383-9. PubMed ID: 10928439
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of neuromuscular and cardiovascular effects of two doses of rapacuronium (ORG 9487) versus mivacurium and succinylcholine.
Miguel R; Witkowski T; Nagashima H; Fragen R; Bartkowski R; Foldes FF; Shanks C
Anesthesiology; 1999 Dec; 91(6):1648-54. PubMed ID: 10598606
[TBL] [Abstract][Full Text] [Related]
47. Observations of the potency and duration of vecuronium in isoflurane-anesthetized horses.
Martin-Flores M; Pare MD; Adams W; Campoy L; Gleed RD
Vet Anaesth Analg; 2012 Jul; 39(4):385-9. PubMed ID: 22642379
[TBL] [Abstract][Full Text] [Related]
48. Does the choice of intravenous induction drug affect intubation conditions after a fast-onset neuromuscular blocker?
El-Orbany MI; Wafai Y; Joseph NJ; Salem MR
J Clin Anesth; 2003 Feb; 15(1):9-14. PubMed ID: 12657404
[TBL] [Abstract][Full Text] [Related]
49. Pharmacokinetics and pharmacodynamics of rapacuronium bromide.
Wight WJ; Wright PM
Clin Pharmacokinet; 2002; 41(13):1059-76. PubMed ID: 12403643
[TBL] [Abstract][Full Text] [Related]
50. Comparisons of the dose-response and recovery time course of vecuronium and atracurium in anesthetized chinese adult patients.
Xue FS; Li P; Liao X; Li CW; Xu YC; Liu Y; Liu KP; Sun HT
Acta Anaesthesiol Taiwan; 2007 Mar; 45(1):9-14. PubMed ID: 17424753
[TBL] [Abstract][Full Text] [Related]
51. Clinical pharmacology of rapacuronium bromide, a new short-acting neuromuscular blocking agent.
Larijani GE; Zafeiridis A; Goldberg ME
Pharmacotherapy; 1999 Oct; 19(10):1118-22. PubMed ID: 10512060
[TBL] [Abstract][Full Text] [Related]
52. Recovery from neuromuscular block in dogs: restoration of spontaneous ventilation does not exclude residual blockade.
Martin-Flores M; Sakai DM; Campoy L; Gleed RD
Vet Anaesth Analg; 2014 May; 41(3):269-77. PubMed ID: 24754501
[TBL] [Abstract][Full Text] [Related]
53. Neuromuscular blocking effects of vecuronium in dogs with autosomal-recessive centronuclear myopathy.
Martin-Flores M; Paré MD; Tomak EA; Corn ML; Campoy L
Am J Vet Res; 2015 Apr; 76(4):302-7. PubMed ID: 25815571
[TBL] [Abstract][Full Text] [Related]
54. The effects of rapacuronium on histamine release and hemodynamics in adult patients undergoing general anesthesia.
Levy JH; Pitts M; Thanopoulos A; Szlam F; Bastian R; Kim J
Anesth Analg; 1999 Aug; 89(2):290-5. PubMed ID: 10439732
[TBL] [Abstract][Full Text] [Related]
55. Comparison of intubating conditions after rapacuronium (Org 9487) and succinylcholine following rapid sequence induction in adult patients.
Sparr HJ; Mellinghoff H; Blobner M; Nöldge-Schomburg G
Br J Anaesth; 1999 Apr; 82(4):537-41. PubMed ID: 10472218
[TBL] [Abstract][Full Text] [Related]
56. The influence of acute normovolemic hemodilution on the dose-response and time course of action of vecuronium.
Xue FS; Liu JH; Liao X; Tong SY; Li L; Zhang RJ; An G; Luo LK
Anesth Analg; 1998 Apr; 86(4):861-6. PubMed ID: 9539616
[TBL] [Abstract][Full Text] [Related]
57. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.
Duvaldestin P; Kuizenga K; Saldien V; Claudius C; Servin F; Klein J; Debaene B; Heeringa M
Anesth Analg; 2010 Jan; 110(1):74-82. PubMed ID: 19933538
[TBL] [Abstract][Full Text] [Related]
58. Elderly patients recover more rapidly from desflurane than from isoflurane anesthesia.
Bennett JA; Lingaraju N; Horrow JC; McElrath T; Keykhah MM
J Clin Anesth; 1992; 4(5):378-81. PubMed ID: 1389191
[TBL] [Abstract][Full Text] [Related]
59. Sevoflurane and isoflurane impair edrophonium reversal of vecuronium-induced neuromuscular block.
Morita T; Kurosaki D; Tsukagoshi H; Sugaya T; Saito S; Sato H; Fujita T
Can J Anaesth; 1996 Aug; 43(8):799-805. PubMed ID: 8840059
[TBL] [Abstract][Full Text] [Related]
60. Sevoflurane exposure time and the neuromuscular blocking effect of vecuronium.
Ahmed AA; Kumagai M; Otake T; Kurata Y; Amaki Y
Can J Anaesth; 1999 May; 46(5 Pt 1):429-32. PubMed ID: 10349921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
